Menopausal Hormone Therapy Reduces Risk of Low Bone Mineral Density by 69%
.jpg&w=3840&q=75)
The title states that Menopausal Hormone Therapy (MHT) significantly reduces the risk of low bone mineral density by 69%. The rest of the provided content consists of website navigation links and membership information for the Endocrine Society.
Why it matters
This finding is significant for women's health, particularly for post-menopausal women, as it suggests a highly effective treatment to prevent osteoporosis and related bone issues, improving quality of life and reducing healthcare burdens.
News Advocacy Awards Endocrine Topics Education & Training Practice Guidelines Journals Meetings & Events Store Hello, Please login Your Account & Tools Learning Claim credits Plan your learning Browse journals and articles View sessions recordings Membership Renew membership Submit Your Science! Find other members Career Get published Earn recognition Develop your career Promote your work Join Login 0 Items Menu Login Sign Up The Latest Our Community Open Submenu Special Interest Groups Career & Professional Development EndoCareers Community & Global Exchange Expanding Field of Endocrinology About Endocrine Society Find an Endocrinologist Advancing Research Open Submenu Scientific Statements Research Opportunities Stay Informed: Scientific Journals Research Fellowships & Programs Research Awards Improving Practice Open Submenu Clinical Practice Guidelines Education & Training Physician Payment: QPP and MACRA Membership Open Submenu Member Rates Renew Membership Member Resources EndoForum Get Involved Membership Toolkit Partnerships Open Submenu Corporate Liaison Board ENDO 2026 Satellite Symposia Guidelines.pdf Advertise With Us JOIN OR RENEW TODAY! News Advocacy Awards Endocrine Topics Education & Training Practice Guidelines Journals Meetings & Events Store JOIN OR RENEW TODAY! Close The Latest Our Community Open Submenu Special Interest Groups Career & Professional Development EndoCareers Community & Global Exchange Expanding Field of Endocrinology About Endocrine Society Find an Endocrinologist Advancing Research Open Submenu Scientific Statements Research Opportunities Stay Informed: Scientific Journals Research Fellowships & Programs Research Awards Improving Practice Open Submenu Clinical Practice Guidelines Education & Training Physician Payment: QPP and MACRA Membership Open Submenu Member Rates Renew Membership Member Resources EndoForum Get Involved Membership Toolkit Partnerships Open Submenu Corporate Liaison Board ENDO 2026 Satellite Symposia Guidelines.pdf Advertise With Us JOIN OR RENEW TODAY! Endocrine News News Room Menopausal Hormone Therapy Reduces Risk of Low Bone Mineral Density by 69% SHARE email facebook twitter bluesky pinterest print Press Release Meetings & Events Menopausal Hormone Therapy Reduces Risk of Low Bone Mineral Density by 69% Chicago, IL June 14, 2026 Women on menopausal hormonal therapy face a decreased risk of low bone mineral density compared to those not using it, according to a study being presented Sunday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.
Presents a scientific finding from a medical society, implying evidence-based information.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in